Anavex Life Sciences Corp (AVXL)

[nidan7500]

LGL...stop me if this sounds familiar to Dr. M's CNS words as well..also rings a little of the FDA Precision Med. work model and other speculation on why the trials delays. Yes, it is a connect the dots exercise but so what.

Miller’s second goal was to shed more light on Parkinson’s and other neurodegenerative diseases, as well as the reason why people with type 2 diabetes have a higher risk for developing PD and not only AD. Miller’s hypothesis was that amylin can also interact with NAC or alpha-synuclein. This study spanned nearly three years of research using sophisticated computer simulations. The findings were then confirmed through experiments.